lt p gt BioElectronics Corporation develops, manufactures, markets and sells consumer medical electronic devices that have both a high efficacy and safety profile for acute and chronic pain. Along with the added benefit of an unmatched cost/benefit ratio, the Company s innovative, miniaturized technology contains an embedded microchip and battery that deliver pulsed electromagnetic field energy, a clinically proven and widely accepted anti inflammatory and pain relief therapy that has only been possible to obtain from large, facility based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch Musculoskeletal Pain Relief, Allay Menstrual Pain Therapy, RecoveryRx Chronic Wounds and Postoperative Recovery, and HealFast Therapy for cats, dogs and horses. The company is headquartered in Frederick, Maryland, USA. BioElectronics is changing the way people heal around the world. Pain has a significant impact on quality of life and with our expanding international presence we are touching the lives of individuals suffering from pain and edema worldwide. Our vision is to provide our highly effective and safe technological solution to pain. We received the Wall Street Journal Technology Innovation Awards with our unique anti inflammatory technology that reduces pain and edema. This technology is the platform for everything that we do. Our current strategic vision is to develop a number of strong brands that build upon our technological platform. Currently, the main applications are aimed at the OTC markets for back pain, knee pain and menstrual pain. We hope to introduce our technology to new markets and additional countries in the near future. lt /p gt
Quote | Bioelectronics Corp (OTCMKTS:BIEL)
Last: | $0.0003 |
---|---|
Change Percent: | -14.29% |
Open: | $0.0004 |
Close: | $0.0003 |
High: | $0.0004 |
Low: | $0.0003 |
Volume: | 4,822,350 |
Last Trade Date Time: | 11/28/2023 03:00:00 am |
News | Bioelectronics Corp (OTCMKTS:BIEL)
Company Receives Initial Purchase Order From Stada MENA FREDERICK, MD - ( NewMediaWire ) - July 22, 2022 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced via a Shareholder’s update that the Company...
BioElectronics (OTCPK:BIEL) entered into a distribution agreement with Madrid / Spain based PRIM for the distribution of its RecoveryRx device across Spain. "PRIM Group in Spain serves as a perfect call point fit to provide a successful distribution of RecoveryRx...
Message Board Posts | Bioelectronics Corp (OTCMKTS:BIEL)
Subject | By | Source | When |
---|---|---|---|
WOW, the saga continues! | art2426 | investorshub | 11/28/2023 8:27:05 PM |
"IMO" And what does your O equal? | prussian4profit | investorshub | 11/28/2023 8:23:09 PM |
LMAO, maybe you should be more concerned about | art2426 | investorshub | 11/28/2023 8:22:34 PM |
This business, for the family, IMO was as | art2426 | investorshub | 11/28/2023 8:12:56 PM |
IF you understood the definition of engage in | prussian4profit | investorshub | 11/28/2023 8:11:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Company Receives Initial Purchase Order From Stada MENA FREDERICK, MD - ( NewMediaWire ) - July 22, 2022 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced via a Shareholder’s update that the Company...
FREDERICK, MD - ( NewMediaWire ) - April 06, 2022 - BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group ( www...
FREDERICK, MD - ( NewMediaWire ) - March 30, 2022 - BioElectronics Corporation ( https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx®...